News of Note—Stent trial controversy, Corindus funding and more

(NS Newsflash/CC BY 2.0)

> Controversy has engulfed a long-running study into the use of stents in patients with stable ischemic heart disease. The row blew up after investigators changed the primary endpoint late in the study. CardioBrief

> Corindus, a provider of robotic-assisted vascular intervention technologies, has put together a $25 million private placement. Statement

> Nexstim has ended negotiations with a potential Chinese distribution partner. The neuromodulation company had hoped to receive a $1.2 million investment through the deal. Release